BMI misclassifies athletic bodies. New research calls for revised BMI cut-offs to better assess young male athletes’ health ...

Results include the following: The 2023 research follows older studies that identified an increased risk of death in older adults when BMI was below 23 or above 33. Taken together, the healthiest ...

Rheumatoid arthritis (RA) patients face very different risks for cardiovascular disease and events depending on their body ...

Clinically meaningful improvements were observed across key secondary endpoints at week 52, including: 83% of patients on setmelanotide therapy achieved 5% or greater reduction in BMI (n=33 ...

83% of patients on setmelanotide therapy achieved 5% or greater reduction in BMI (n=33 patients 18 or older) or BMI Z-score reduction of 0.2 or greater points (n=48 patients younger than 18).

Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) on Monday released topline results from the pivotal Phase 3 TRANSCEND trial evaluating setmelanotide, a melanocortin-4 receptor (MC4R) agonist, for the ...